Cellebrite Di Equity Stock Short Ratio
| CLBTWDelisted Stock | USD 5.15 0.44 7.87% |
Cellebrite DI Equity fundamentals help investors to digest information that contributes to Cellebrite's financial success or failures. It also enables traders to predict the movement of Cellebrite Stock. The fundamental analysis module provides a way to measure Cellebrite's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellebrite stock.
Cellebrite |
Cellebrite DI Equity Company Short Ratio Analysis
Cellebrite's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Cellebrite DI Equity has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Software sector and about the same as Information Technology (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Cellebrite Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellebrite's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellebrite could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics of similar companies.Cellebrite is currently under evaluation in short ratio category among its peers.
Cellebrite Fundamentals
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.13 % | |||
| Number Of Shares Shorted | 356.81 K | |||
| Price To Earning | 12.50 X | |||
| Revenue | 325.11 M | |||
| Gross Profit | 219.91 M | |||
| EBITDA | 43.29 M | |||
| Net Income | (81.1 M) | |||
| Total Debt | 14.13 M | |||
| Book Value Per Share | (0.19) X | |||
| Cash Flow From Operations | 102.06 M | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 1.01 K | |||
| Beta | 1.52 | |||
| Total Asset | 540.4 M | |||
| Retained Earnings | 118.14 M | |||
| Working Capital | 168.26 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 540.4 M |
About Cellebrite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellebrite DI Equity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellebrite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellebrite DI Equity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Cellebrite Stock
If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |